Thrombelastography Based Dosing of Enoxaparin

NCT00990236 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

185

Enrollment

OTHER

Sponsor class

Conditions

Thromboembolic Complications

Interventions

DRUG: Enoxaparin dose adjusted Lovenox based on TEG
DRUG: Enoxaparin 30 mg BID

Sponsor

Oregon Health and Science University

Collaborators

[object Object]
[object Object]